Manufacture And Supply Agreement Sample Contracts

Share Cite Term
Link

Embed (HTML)
OptiNose, Inc. – Manufacture and Supply Agreement (September 18th, 2017)

This MANUFACTURE AND SUPPLY AGREEMENT (the Agreement) is made as of August 18, 2017 (the Effective Date) by and among, on the one hand, OptiNose US, Inc., duly organized and existing under the laws of Delaware and having offices located at 1020 Stony Hill Road, Suite 300, Yardley, PA 19067 (referred to herein as OptiNose US), OptiNose UK Ltd. duly organized and existing under the laws of England and having offices located at Hunts Rise, South Marston Park, Wiltshire, SN3 4TG, England (referred to herein as OptiNose UK), and OptiNose AS, duly organized and existing under the laws of Norway and having offices located at Gaustadalleen 21 0349 Oslo, Norway (referred to herein as OptiNose Norway, and collectively with OptiNose US and OptiNose UK, OptiNose), and, on the other hand, Contract Pharmaceuticals Limited Canada, duly organized under the laws of the Province of Ontario and having offices located at 7600 Danbro Crescent, Mississauga, Ontario Canada L5N 6L6 (referred to herein as CPL)

OptiNose, Inc. – Manufacture and Supply Agreement (August 31st, 2017)

This MANUFACTURE AND SUPPLY AGREEMENT (the Agreement) is made as of August 18, 2017 (the Effective Date) by and among, on the one hand, OptiNose US, Inc., duly organized and existing under the laws of Delaware and having offices located at 1020 Stony Hill Road, Suite 300, Yardley, PA 19067 (referred to herein as OptiNose US), OptiNose UK Ltd. duly organized and existing under the laws of England and having offices located at Hunts Rise, South Marston Park, Wiltshire, SN3 4TG, England (referred to herein as OptiNose UK), and OptiNose AS, duly organized and existing under the laws of Norway and having offices located at Gaustadalleen 21 0349 Oslo, Norway (referred to herein as OptiNose Norway, and collectively with OptiNose US and OptiNose UK, OptiNose), and, on the other hand, Contract Pharmaceuticals Limited Canada, duly organized under the laws of the Province of Ontario and having offices located at 7600 Danbro Crescent, Mississauga, Ontario Canada L5N 6L6 (referred to herein as CPL)

Kindred Biosciences, Inc. – ZIMETA (DIPYRONE INJECTION) COMMERCIAL MANUFACTURE AND SUPPLY AGREEMENT June 21, 2017 (June 26th, 2017)

THIS ZIMETA (DIPYRONE INJECTION) COMMERCIAL MANUFACTURE AND SUPPLY AGREEMENT (this "Agreement") is made as of June 21, 2017 (the "Effective Date") between Kindred Biosciences, Inc., a Delaware corporation ("KindredBio"), and Corden Pharma S.p.A, an Italian shared company ("Corden").

Alphatec Holdings – Product Manufacture and Supply Agreement (November 9th, 2016)

This Product Manufacture and Supply Agreement (this "Agreement") is entered into as of the 1st day of September, 2016 (the "Effective Date"), by and between Alphatec Holdings, Inc., a corporation organized and existing under the laws of the State of Delaware and having its principal office at 5818 El Camino Real, Carlsbad, California 92008, USA ("Alphatec"), and Globus Medical Ireland, Ltd., a private limited company organized and existing under the laws of Ireland and having its principal office at Valley Forge Business Center, 2560 General Armistead Avenue, Audubon, Pennsylvania 19403, USA ("Globus").

Rocky Mountain High Brands, Inc. – Exclusive Manufacture and Supply Agreement (June 22nd, 2016)
Manufacture and Supply Agreement (November 13th, 2015)

This MANUFACTURE AND SUPPLY AGREEMENT (Agreement) is entered into as of the date of the last signature below (the Effective Date) between:

Acelrx Pharmaceuticals – First Amendment to the Manufacture and Supply Agreement Dated December 16, 2013 (November 3rd, 2015)

This First Amendment to Manufacture and Supply Agreement (this "Amendment") entered into as of 17 July, 2015 (the "Effective Date") between AcelRx Pharmaceuticals, Inc., a company organized under the laws of the State of Delaware, United States ("AcelRx"), and having a principal place of business at 351 Galveston Drive, Redwood City, CA 94063, United States, and Grunenthal GmbH, a company organized under the laws of Germany ("Grunenthal"), having its registered office at Zieglerstrasse 6, 52078 Aachen, Germany.

Innocoll GmbH – Amended and Restated Manufacture and Supply Agreement (July 24th, 2014)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment under Rule 406 under the Securities Act of 1933, as amended. Confidential portions are marked: [ *** ]

Innocoll GmbH – Amended and Restated Manufacture and Supply Agreement (June 19th, 2014)

This Amended and Restated Manufacture and Supply Agreement (this "Agreement") is entered into as of April 27, 2010 (the "Restated MSA Effective Date") by and among Innocoll Pharmaceuticals Limited, a corporation organized and existing under the laws of Ireland ("Innocoll Pharmaceuticals"), and Syntacoll AG, a company organized under the laws of Switzerland ("Syntacoll") all located at c/o Innocoll Holdings, Inc. 42662 Kitchen Prim Ct., Ashburn, VA 20148 (Innocoll Pharmaceuticals and Syntacoll shall collectively be referred to herein as "Innocoll"),

Acelrx Pharmaceuticals – Manufacture and Supply Agreement (May 13th, 2014)

This MANUFACTURE AND SUPPLY AGREEMENT (Agreement) is entered into as of December 16, 2013 (the Effective Date) between ACELRX PHARMACEUTICALS, INC., a company organized under the laws of the State of Delaware, United States (AcelRx), and having a principal place of business at 575 Chesapeake Drive, Redwood City, CA 94063, United States, and GRUNENTHAL GMBH, a company organized under the laws of Germany (Grunenthal), having its registered office at Zieglerstrasse 6, 52078 Aachen, Germany. AcelRx and Grunenthal may be referred to herein from time to time individually as a Party, and collectively as the Parties.

Ocera Therapeutics – Clinical Manufacture and Supply Agreement (September 27th, 2013)

THIS CLINICAL MANUFACTURE AND SUPPLY AGREEMENT (the "Agreement") is entered into as of December 22, 2005 (the "CSA Effective Date"), by and between OCERA THERAPEUTICS, INC. ("Ocera"), a Delaware corporation, having an address of 11622 El Camino Real, Suite 100, San Diego, CA 92130, United States of America, and KUREHA CORPORATION, a Japanese corporation ("Kureha"), having an address of 3-3-2, Nihonbashi Hama-cho, Chuo-ku, Tokyo 103-8552, Japan.

Enzymotec Ltd. – Re: Amendment to Manufacture and Supply Agreement (September 27th, 2013)

Enzymotec Ltd., and PUNJAB Chemicals and Corp Protection Ltd. (Pharma Div.-Alpha Drug), are parties to a Manufacture and Supply Agreement dated February 15, 2009 (the "Agreement"). The parties would like to make certain Amendment to the Agreement as follows:

Enzymotec Ltd. – Manufacture and Supply Agreement (September 27th, 2013)

This Manufacture and Supply Agreement is made and entered into as of the 15 day of February, 2009 (the "Effective Date"), by and between Enzymotec Ltd., an Israeli company ("Enzymotec") and PUNJAB Chemicals and Corp Protection Ltd., an Indian company ("Manufacturer"). Enzymotec and Manufacturer are sometimes herein referred to individually as a "party" and collectively the "parties".

Ocera Therapeutics – Commercial Manufacture and Supply Agreement (September 27th, 2013)

THIS COMMERCIAL MANUFACTURE AND SUPPLY AGREEMENT (the "Agreement") is entered into as of November 1st, 2007 (the "Effective Date"), by and between OCERA THERAPEUTICS, INC. ("Ocera"), a Delaware corporation, having an address of 12651 High Bluff Drive, Suite 230, San Diego, CA 92130, United States of America, and KUREHA CORPORATION, a Japanese corporation ("Kureha"), having an address of 3-3-2, Nihonbashi Hama-cho, Chuo-ku, Tokyo 103-8552, Japan.

Enzymotec Ltd. – Re: Amendment to Manufacture and Supply Agreement (July 10th, 2013)

Enzymotec Ltd., and PUNJAB Chemicals and Corp Protection Ltd. (Pharma Div.-Alpha Drug), are parties to a Manufacture and Supply Agreement dated February 15, 2009 (the "Agreement"). The parties would like to make certain Amendment to the Agreement as follows:

Enzymotec Ltd. – Manufacture and Supply Agreement (July 10th, 2013)

This Manufacture and Supply Agreement is made and entered into as of the 15 day of February, 2009 (the "Effective Date"), by and between Enzymotec Ltd., an Israeli company ("Enzymotec") and PUNJAB Chemicals and Corp Protection Ltd., an Indian company ("Manufacturer"). Enzymotec and Manufacturer are sometimes herein referred to individually as a "party" and collectively the "parties".

Nxt-ID, Inc. – Samples Manufacture and Supply Agreement (May 6th, 2013)

This Samples Manufacture and Supply Agreement ("Agreement") is entered into this 18th day of January, 2013 (the "Effective Date"), by and between:

Nxt-ID, Inc. – Samples Manufacture and Supply Agreement (March 25th, 2013)

This Samples Manufacture and Supply Agreement ("Agreement") is entered into this 18th day of January, 2013 (the "Effective Date"), by and between:

Manufacture and Supply Agreement (October 28th, 2011)

THIS MANUFACTURE AND SUPPLY AGREEMENT (this Agreement), effective as of May 16, 2011 (the Effective Date), is made and entered into by and between Codexis, Inc., a Delaware corporation, having a place of business at 200 Penobscot Drive, Redwood City, California 94063, USA (Codexis), and Lactosan GmbH & Co. KG, a corporation organized and existing under the laws of Austria, having a place of business at Industriestrasse West 5, A-8605 Kapfenberg, Austria (Company). Codexis and Company each may be referred to herein individually as a Party, or collectively as the Parties.

Manufacture and Supply Agreement (August 3rd, 2011)

THIS MANUFACTURE AND SUPPLY AGREEMENT (this Agreement), effective as of May 16, 2011 (the Effective Date), is made and entered into by and between Codexis, Inc., a Delaware corporation, having a place of business at 200 Penobscot Drive, Redwood City, California 94063, USA (Codexis), and Lactosan GmbH & Co. KG, a corporation organized and existing under the laws of Austria, having a place of business at Industriestrasse West 5, A-8605 Kapfenberg, Austria (Company). Codexis and Company each may be referred to herein individually as a Party, or collectively as the Parties.

Fourth Amended and Restated Membrane Manufacture and Supply Agreement (April 22nd, 2011)

This Fourth Amended and Restated Membrane Manufacture and Supply Agreement (this Agreement) is entered into effective as of January 10, 2011 (the Effective Date), between Millipore Corporation (Millipore), a Massachusetts corporation with its principal place of business at 290 Concord Road, Billerica, MA 01821, and Entegris, Inc. (Entegris), a Delaware corporation with its principal place of business at 3500 Lyman Boulevard, Chaska, MN 55318.

Sagent Pharmaceuticals Inc. – Manufacture and Supply Agreement (February 2nd, 2011)

This Manufacture and Supply Agreement (this Agreement) is made and entered into as of December 17, 2007 (the Effective Date) by and among A.C.S. Dobfar S.p.a., an Italian corporation, having its principal place of business at Viale Addetta, 4/12 Tribiano 20067 Milan Italy (DOBFAR or SUPPLIER), WorldGen LLC, a New Jersey Limited Liability Company, having its principal place of business at 120 Route 17 North P.O. Box 1579 Paramus, NJ 07653 USA (WORLDGEN), and SAGENT PHARMACEUTICALS, INC., a Wyoming corporation, having its principal place of business at 1901 N. Roselle Road, Schaumburg, IL 60195 (SAGENT).

Sagent Pharmaceuticals Inc. – Manufacture and Supply Agreement (December 6th, 2010)

This Manufacture and Supply Agreement (this Agreement) is made and entered into as of December 17, 2007 (the Effective Date) by and among A.C.S. Dobfar S.p.a., an Italian corporation, having its principal place of business at Viale Addetta, 4/12 Tribiano 20067 Milan Italy (DOBFAR or SUPPLIER), WorldGen LLC, a New Jersey Limited Liability Company, having its principal place of business at 120 Route 17 North P.O. Box 1579 Paramus, NJ 07653 USA (WORLDGEN), and SAGENT PHARMACEUTICALS, INC., a Wyoming corporation, having its principal place of business at 1901 N. Roselle Road, Schaumburg, IL 60195 (SAGENT).

Navidea Biopharmaceuticals, Inc. – Manufacture and Supply Agreement (August 10th, 2010)

THIS MANUFACTURE AND SUPPLY AGREEMENT is entered into this 30th day of November 2009, by and between Reliable Biopharmaceutical Corporation, a corporation organized under the laws of the State of Missouri, with its principal offices located at 1945 Walton Road, St. Louis, Missouri 63114 ("RELIABLE") and Neoprobe Corporation, a corporation organized under the laws of the State of Delaware, with offices located at 425 Metro Place North, Suite 300, Dublin, Ohio 43017-1367 ("NEOPROBE").

Gold & Gemstone Mining Inc. – Product Manufacture and Supply Agreement (April 7th, 2010)

This Agreement made this 25th day of February 2010 by and between Global GSM Solutions Inc. having a principal place of business at 204 West Spear Street Carson City NV 89703 ("Purchaser") and XTEK, an software/hardware developer, having a principal office in name Kusocinskiego 3 street 87-100 Torun, Poland.

Alexza Pharmaceuticals – Manufacture and Supply Agreement (March 9th, 2010)

This MANUFACTURE AND SUPPLY AGREEMENT (Agreement) is made and effective as of February 9, 2010 (the Effective Date) by and between Alexza Pharmaceuticals, Inc., a Delaware corporation having a place of business at 2091 Stierlin Court, Mountain View, CA 94043 (Alexza), and Biovail Laboratories International SRL, a Barbados society with restricted liability having its registered office at Welches, Christ Church, Barbados, WI, BB17154 (BLS). Alexza and BLS may be referred to herein from time to time individually as a Party, and collectively as the Parties.

Third Amended and Restated Membrane Manufacture and Supply Agreement (February 26th, 2010)

This Third Amended and Restated Membrane Manufacture and Supply Agreement (this Agreement) is entered into effective as of October 13, 2009 (the Effective Date), between Millipore Corporation (Millipore), a Massachusetts corporation with its principal place of business at 290 Concord Road, Billerica, MA 01821, and Entegris, Inc. (Entegris), a Delaware corporation with its principal place of business at 3500 Lyman Boulevard, Chaska, MN 55318.

Second Amended and Restated Membrane Manufacture and Supply Agreement (March 2nd, 2009)

This Second Amended and Restated Membrane Manufacture and Supply Agreement (this Agreement) is entered into effective as of December 19, 2008 (the Effective Date), between Millipore Corporation (Millipore), a Massachusetts corporation with its principal place of business at 290 Concord Road, Billerica, MA 01821, and Entegris, Inc. (Entegris), a Delaware corporation with its principal place of business at 3500 Lyman Boulevard, Chaska, MN 55318.

TOM Online – Manufacture and Supply Agreement (January 16th, 2009)

This Agreement made as of this 8th day of October 2008, by and between Siemens AG Healthcare Sector, Components & Vacuum Technology, having a business address at Henkestrasse 127, 91052 Erlangen, Germany (Seller) and TomoTherapy Incorporated, having a business address at 1240 Deming Way, Madison, WI 53717, USA (Buyer).

Manufacture and Supply Agreement (August 7th, 2008)

THIS MANUFACTURE AND SUPPLY AGREEMENT is made as of September 8, 2005 (the Effective Date), by and between ACCLARENT, INC., a Delaware Corporation with a principal place of business in Menlo Park, California, and with a mailing address of 1525-B OBrien Drive, Menlo Park, California, 94025 (hereinafter referred to as Acclarent), and ADVANCED POLYMERS, INC., a New Hampshire corporation duly organized and existing under the laws of the State of New Hampshire, having its principal place of business in Salem, New Hampshire, and with a mailing address of 29 Northwestern Drive, Salem, New Hampshire, 03079, (hereinafter referred to as Advanced).

Manufacture and Supply Agreement (June 6th, 2008)

THIS MANUFACTURE AND SUPPLY AGREEMENT is made as of September 8, 2005 (the Effective Date), by and between ACCLARENT, INC., a Delaware Corporation with a principal place of business in Menlo Park, California, and with a mailing address of 1525-B OBrien Drive, Menlo Park, California, 94025 (hereinafter referred to as Acclarent), and ADVANCED POLYMERS, INC., a New Hampshire corporation duly organized and existing under the laws of the State of New Hampshire, having its principal place of business in Salem, New Hampshire, and with a mailing address of 29 Northwestern Drive, Salem, New Hampshire, 03079, (hereinafter referred to as Advanced).

Draxis Health Inc. – MANUFACTURE AND SUPPLY AGREEMENT BETWEEN DRAXIS PHARMA, a Division of DRAXIS SPECIALTY PHARMACEUTICALS INC. AND JOHNSON & JOHNSON CONSUMER COMPANIES, INC. AS OF SEPTEMBER 4, 2007 (March 31st, 2008)

This Manufacturing and Supply Agreement (the Agreement), is entered into as of September 4, 2007 (the Effective Date), by and between Johnson & Johnson Consumer Companies, Inc., a New Jersey corporation (Buyer), and DRAXIS Pharma, a division of DRAXIS Specialty Pharmaceuticals Inc., a Canadian corporation (Manufacturer). Buyer and Manufacturer are each a Party and are collectively, the Parties.

Ciphergen Biosystems – Manufacture and Supply Agreement (November 27th, 2007)

THIS MANUFACTURE AND SUPPLY AGREEMENT (the Agreement), dated November 13, 2006, is between BIO-RAD LABORATORIES, INC., a Delaware corporation with offices at 1000 Alfred Nobel Drive, Hercules, California 94547 (BIO-RAD) and CIPHERGEN BIOSYSTEMS, INC., a Delaware corporation with offices at 6611 Dumbarton Circle, Fremont, California 94555 (CIPHERGEN).

Ciphergen Biosystems – Amendment No. 1 to Manufacture and Supply Agreement Between Bio-Rad Laboratories, Inc. And Ciphergen Biosystems, Inc. (September 27th, 2007)

This AMENDMENT NO. 1 (this Amendment), dated August 27, 2007 (the Effective Date), amends the Manufacture and Supply Agreement between BIO-RAD LABORATORIES, INC. (BIO-RAD) and CIPHERGEN BIOSYSTEMS, INC. (CIPHERGEN), dated November 13, 2006 (the Agreement). The parties hereby agree as follows:

TOM Online – Manufacture and Supply Agreement (April 19th, 2007)

This Agreement made as of this 14 day of November 2003 by and between Siemens Medical Solutions, USA, Inc., acting through and on behalf of its Oncology Care Systems Group having a business address at 4040 Nelson Avenue, Concord, CA 94520 (Seller) and Tomo Therapy, Incorporated, having a business address at 1240 Deming Way, Madison, WI 53717 (Buyer).